025sek
-0,6 %
Date:2026-07-15Time:12:10:43Latest report:Q1-2026List:First NorthTicker:ACARIX
Market Cap:311 msekEnterprise Value:286 msekNet Sales:8,06 msekEarnings:-42,8 msekEmployees:0ISIN:SE0009268717

Ratios

10-year key figure history for Acarix turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Acarix with index and moving average MA50 and MA200.

Stockprice:0,25
MA50:0,26
MA200:0,28
Price/MA200:-10,5 %
RSI (14):41,7
Price/MA50:-3,8 %

Description

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Medical Equipment